检索结果 - Monique Dail

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity

    EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity 由 Mitchell Koolpe, Rosemary Burgess, Monique Dail, Elena B. Pasquale

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells

    Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells 由 Amit J. Sabnis, Laurene S. Cheung, Monique Dail, Hio Chung Kang, Marianne Santaguida, Michelle L. Hermiston, Emmanuelle Passegué, Kevin Shannon, Benjamin S. Braun

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Mutant <i> Ikzf1, Kras <sup>G12D</sup> </i> , and <i>Notch1</i> cooperate in T lineage leukemogenesis and modulate responses to targeted agents

    Mutant <i> Ikzf1, Kras <sup>G12D</sup> </i> , and <i>Notch1</i> cooperate in T lineage leukemogenesis and modulate responses to targeted agents 由 Monique Dail, Qing Li, Andrew S. McDaniel, Jason W.H. Wong, Keiko Akagi, Benjamin J. Huang, Hio Chung Kang, Scott C. Kogan, Kevan M. Shokat, Linda Wolff, Benjamin S. Braun, Kevin Shannon

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models

    Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models 由 Raghuveer Singh Mali, Qi Zhang, RosaAnna DeFilippis, Antonio Cavazos, Vinitha M. Kuruvilla, Jayant Raman, Vidhi Mody, Edna F. Choo, Monique Dail, Neil P. Shah, Marina Konopleva, Deepak Sampath, Elisabeth A. Lasater

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine

    Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine 由 Daniel A. Pollyea, Keith W. Pratz, Andrew H. Wei, Vinod Pullarkat, Brian A. Jonas, Christian Récher, Sunil Babu, Andre C. Schuh, Monique Dail, Yan Sun, Jalaja Potluri, Brenda Chyla, Courtney D. DiNardo

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Impact of <i>F</i> <i>LT3</i> Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia

    Impact of <i>F</i> <i>LT3</i> Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia 由 Marina Konopleva, Michael J. Thirman, Keith W. Pratz, Jacqueline S. Garcia, Christian Récher, Vinod Pullarkat, Hagop M. Kantarjian, Courtney D. DiNardo, Monique Dail, Yinghui Duan, Brenda Chyla, Jalaja Potluri, Catherine L. Miller, Andrew H. Wei

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Venetoclax in Combination with Hypomethylating Agents Induces Rapid, Deep, and Durable Responses in Patients with AML Ineligible for Intensive Therapy

    Venetoclax in Combination with Hypomethylating Agents Induces Rapid, Deep, and Durable Responses in Patients with AML Ineligible for Intensive Therapy 由 Daniel A. Pollyea, Keith W. Pratz, Brian A. Jonas, Anthony Letai, Vinod Pullarkat, Andrew H. Wei, Marina Konopleva, Christian Récher, Olga Frankfurt, David A. Rizzieri, Tu Xu, Monique Dail, Brenda Chyla, Jalaja Potluri, Courtney D. DiNardo

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine

    ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine 由 Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat, Michael J. Thirman, Christian Récher, Andre C. Schuh, Sunil Babu, Monique Dail, Grace Ku, Yan Sun, Jalaja Potluri, Brenda Chyla, Daniel A. Pollyea

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia

    Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia 由 Monique Dail, Jason W.H. Wong, Jessica Lawrence, Daniel P. O’Connor, Joy Nakitandwe, Shann-Ching Chen, Jin Xu, Leslie B. Lee, Keiko Akagi, Qing Li, Jon C. Aster, Warren S. Pear, James R. Downing, Deepak Sampath, Kevin Shannon

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations

    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations 由 Daniel A. Pollyea, Courtney D. DiNardo, Martha Arellano, Arnaud Pigneux, Walter Fiedler, Marina Konopleva, David A. Rizzieri, B. Douglas Smith, Atsushi Shinagawa, Roberto M. Lemoli, Monique Dail, Yinghui Duan, Brenda Chyla, Jalaja Potluri, Catherine L. Miller, Hagop M. Kantarjian

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis

    Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis 由 Christopher Hartzell, Olga Ksionda, Ed Lemmens, Kristen M. Coakley, Ming Yang, Monique Dail, Richard C. Harvey, Christopher C. Govern, Jeroen Bakker, Tineke L. Lenstra, Kristin Ammon, Anne Boeter, Stuart S. Winter, Mignon L. Loh, Kevin Shannon, Arup K. Chakraborty, Matthias Wabl, Jeroen P. Roose

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma 由 Luciano J. Costa, Faith E. Davies, Gregory Monohan, Tibor Kovacsovics, Nicholas Burwick, Andrzej Jakubowiak, Jonathan L. Kaufman, Wan‐Jen Hong, Monique Dail, Ahmed Hamed Salem, Xiaoqing Yang, Abdullah Al Masud, Wijith Munasinghe, Jeremy A. Ross, Orlando F. Bueno, Shaji Kumar, Edward A. Stadtmauer

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine

    Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine 由 Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo, Andrew H. Wei, Brian A. Jonas, Vinod Pullarkat, Michael J. Thirman, Christian Récher, Andre C. Schuh, Sunil Babu, Xiaotong Li, Grace Ku, Zihuan Liu, Yan Sun, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A. Pollyea

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

    Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine 由 Keith W. Pratz, Brian A. Jonas, Vinod Pullarkat, Christian Récher, Andre C. Schuh, Michael J. Thirman, Jacqueline S. Garcia, Courtney D. DiNardo, Vladimir Vorobyev, Nicola Fracchiolla, Su‐Peng Yeh, Jun Ho Jang, Muhi̇t Özcan, Kazuhito Yamamoto, Árpád Illés, Ying Zhou, Monique Dail, Brenda Chyla, Jalaja Potluri, Hartmut Döhner

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia

    Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia 由 Naval Daver, Alexander E. Perl, Joseph Maly, Mark J. Levis, Ellen K. Ritchie, Mark R. Litzow, James McCloskey, Catherine C. Smith, Gary J. Schiller, Terrence Bradley, Ramón V. Tiu, Kiran Naqvi, Monique Dail, Deanna J. Brackman, Satya R. Siddani, Jing Wang, Brenda Chyla, Paul Lee, Jessica K. Altman

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

    Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models 由 Lina Han, Qi Zhang, Monique Dail, Ce Shi, Antonio Cavazos, Vivian Ruvolo, Yang Zhao, Eugene S. Kim, Mohamed Rahmani, Duncan H. Mak, Sha Jin, Jun Chen, Darren C. Phillips, Paul Koller, Rodrigo Jácamo, Jared K. Burks, Courtney D. DiNardo, Naval Daver, Elias Jabbour, Jing Wang, Hagop M. Kantarjian, Michael Andreeff, Steven Grant, Joel D. Leverson, Deepak Sampath, Marina Konopleva

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia

    Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia 由 Anica M. Wandler, Benjamin J. Huang, Jeffrey W. Craig, Kathryn Hayes, Hannah H. Yan, Lauren K. Meyer, Alessandro Scacchetti, Gabriela C. Monsalve, Monique Dail, Qing Li, Jasmine C. Wong, Olga K. Weinberg, Robert P. Hasserjian, Scott C. Kogan, Philip Jonsson, Keith R. Yamamoto, Deepak Sampath, Joy Nakitandwe, James R. Downing, Jinghui Zhang, Jon C. Aster, Barry S. Taylor, Kevin Shannon

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

    Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial 由 Naval Daver, Monique Dail, Jacqueline S. Garcia, Brian A. Jonas, Karen Yee, Kevin R. Kelly, Norbert Vey, Sarit Assouline, Gail J. Roboz, Stefania Paolini, Daniel A. Pollyea, Agostino Tafuri, Joseph Brandwein, Arnaud Pigneux, Bayard L. Powell, Pierre Fenaux, Rebecca L. Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion Ott, Wan‐Jen Hong, Marina Konopleva, Michael Andreeff

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance

    RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance 由 Vanessa E. Kennedy, Cheryl A.C. Peretz, Anushka Walia, Brenda Chyla, Yan Sun, Jason E. Hill, Elaine Tran, Andrew Koh, Timothy T. Ferng, Samantha M. Pintar, Matthew F. Jones, Bogdan Popescu, Natália Faraj Murad, Ritu Roy, Adam B. Olshen, Sunil Joshi, Elie Traer, Monique Dail, Habib Hamidi, Jessica K. Altman, Naval Daver, Mark J. Levis, James McCloskey, Alexander E. Perl, Catherine C. Smith

    出版 2025
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:

检索工具: